Bilirubin treatment in humans; a study on safety and dose finding.
Recruiting
- Conditions
- bilirubin, bilirubine, hart- en vaatziekten, cardiovascular disease
- Registration Number
- NL-OMON25884
- Lead Sponsor
- Radboud University Nijmegen Medical Centre
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 6
Inclusion Criteria
At least 18 and not older than 65 years of age.
Exclusion Criteria
1. Cocumented history of sensitivity or indiosyncrasy to medicinal products or excipients;
2. History of or current abuse of drugs, alcohol or solvents;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bilirubin concentrations attained after parenteral administration.
- Secondary Outcome Measures
Name Time Method Safety parameters including for example body temperature, heart rate and blood pressure.